window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 28, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

cell therapy manufacturing

  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain

    Cellares secures $50M investment to expand automated cell therapy manufacturing

    Cellares has secured a $50 million growth equity investment from [...]

    June 16, 2026
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain

    Cellares raises $277M Series D as ARK Invest backs cell therapy manufacturing

    Cellares has expanded its Series D financing to $277 million [...]

    June 10, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain

    Sartorius launches Eveo platform targeting cell therapy manufacturing bottlenecks

    Sartorius has launched a new platform designed to address manufacturing [...]

    May 5, 2026
  • Advanced Therapies,Manufacturing & Supply Chain

    University of Chicago team completes first automated 3-in-1 TCR-T manufacturing run on Quantum Flex bioreactor

    Terumo Blood and Cell Technologies has reported what it described [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Adva Biotechnology and Autolomous launch digital pioneer program for scalable autologous cell therapy manufacturing

    Adva Biotechnology Ltd. and Autolomous Ltd. have announced a strategic [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    Adva Biotechnology and Autolomous launch program to scale digital manufacturing of autologous cell therapies

    Adva Biotechnology and Autolomous have announced a collaboration to co-lead [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    Galapagos taps CELLforCURE by SEQENS to manufacture CAR-T therapy in France

    CELLforCURE by SEQENS has partnered with Galapagos to manufacture GLPG5101, [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kayentis launches AI-powered eConsent tool for clinical trials
    Categories: Clinical & Regulatory, Digital & Data
  • Orphan Therapeutics Accelerator expands rare disease development network to advance ultra-rare therapies
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Phase 2 trial begins for fetal growth restriction therapy with no approved drug treatments available
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top